OAM
GILD icon

OP Asset Management’s Gilead Sciences GILD Stock Holding History

OP Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7M Sell
139,908
-79,652
-36% -$10.5M 0.19% 90
2026
Q1 		$30.6M Buy
219,560
+81,019
+58% +$11.3M 0.26% 52
2025
Q4 		$17M Buy
138,541
+1,854
+1% +$225K 0.21% 84
2025
Q3 		$15.2M Buy
136,687
+2,669
+2% +$303K 0.2% 90
2025
Q2 		$14.9M Buy
134,018
+1,686
+1% +$179K 0.22% 81
2025
Q1 		$14.8M Buy
+132,332
New +$13.7M 0.25% 72

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OP Asset Management's GILD Position: Q2 2026 in Review

OP Asset Management reduced its Gilead Sciences (GILD) stake by 36% in Q2 2026, selling an estimated $10.5M and leaving 139,908 shares worth $17.7M. The position accounts for 0.19% of the portfolio, ranked #90.

OP Asset Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $30.6M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • OP Asset Management held 139,908 shares of Gilead Sciences worth $17.7M as of Q2 2026.
  • OP Asset Management sold 79,652 Gilead Sciences shares in Q2 2026, an estimated $10.5M.
  • Gilead Sciences made up 0.19% of OP Asset Management's portfolio in Q2 2026, its #90 holding.
  • OP Asset Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Gilead Sciences position peaked at $30.6M in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.